JP2006521335A5 - - Google Patents

Download PDF

Info

Publication number
JP2006521335A5
JP2006521335A5 JP2006505892A JP2006505892A JP2006521335A5 JP 2006521335 A5 JP2006521335 A5 JP 2006521335A5 JP 2006505892 A JP2006505892 A JP 2006505892A JP 2006505892 A JP2006505892 A JP 2006505892A JP 2006521335 A5 JP2006521335 A5 JP 2006521335A5
Authority
JP
Japan
Prior art keywords
group
compound
compound according
hydrocarbyl
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006505892A
Other languages
English (en)
Japanese (ja)
Other versions
JP4719144B2 (ja
JP2006521335A (ja
Filing date
Publication date
Priority claimed from GB0306717A external-priority patent/GB0306717D0/en
Priority claimed from GB0315885A external-priority patent/GB0315885D0/en
Application filed filed Critical
Priority claimed from PCT/GB2004/000705 external-priority patent/WO2004085459A1/en
Publication of JP2006521335A publication Critical patent/JP2006521335A/ja
Publication of JP2006521335A5 publication Critical patent/JP2006521335A5/ja
Application granted granted Critical
Publication of JP4719144B2 publication Critical patent/JP4719144B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006505892A 2003-03-24 2004-02-20 ステロイドスルファターゼのインヒビターとしてのエストロゲン誘導体 Expired - Fee Related JP4719144B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0306717.0 2003-03-24
GB0306717A GB0306717D0 (en) 2003-03-24 2003-03-24 Compound
GB0315885.4 2003-07-07
GB0315885A GB0315885D0 (en) 2003-07-07 2003-07-07 Compound
PCT/GB2004/000705 WO2004085459A1 (en) 2003-03-24 2004-02-20 Oestrogen derivatives as inhibitors of steroid sulphatase

Publications (3)

Publication Number Publication Date
JP2006521335A JP2006521335A (ja) 2006-09-21
JP2006521335A5 true JP2006521335A5 (cg-RX-API-DMAC10.html) 2007-03-01
JP4719144B2 JP4719144B2 (ja) 2011-07-06

Family

ID=33099976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505892A Expired - Fee Related JP4719144B2 (ja) 2003-03-24 2004-02-20 ステロイドスルファターゼのインヒビターとしてのエストロゲン誘導体

Country Status (14)

Country Link
US (1) US7893284B2 (cg-RX-API-DMAC10.html)
EP (1) EP1608671B1 (cg-RX-API-DMAC10.html)
JP (1) JP4719144B2 (cg-RX-API-DMAC10.html)
AT (1) ATE454395T1 (cg-RX-API-DMAC10.html)
AU (1) AU2004224053B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0408703A (cg-RX-API-DMAC10.html)
CA (1) CA2520142C (cg-RX-API-DMAC10.html)
DE (1) DE602004024966D1 (cg-RX-API-DMAC10.html)
DK (1) DK1608671T3 (cg-RX-API-DMAC10.html)
EA (1) EA011123B1 (cg-RX-API-DMAC10.html)
ES (1) ES2339450T3 (cg-RX-API-DMAC10.html)
MX (1) MXPA05010339A (cg-RX-API-DMAC10.html)
PL (1) PL378577A1 (cg-RX-API-DMAC10.html)
WO (1) WO2004085459A1 (cg-RX-API-DMAC10.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113920D0 (en) 2001-06-07 2001-08-01 Sterix Ltd Composition
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
US8288367B2 (en) 2006-11-30 2012-10-16 Solvay Pharmaceuticals Gmbh Substituted estratriene derivatives as 17BETA HSD inhibitors
WO2008090517A2 (en) * 2007-01-26 2008-07-31 Piramal Life Sciences Limited Enriched plant extract, compound, and methods for the treatment of proliferative disorders
EP2149371A1 (en) 2008-07-28 2010-02-03 PregLem S.A. Use of steroid sulfatase inhibitors for the treatment of preterm labor
EP2334686B1 (en) 2008-08-28 2019-02-27 President and Fellows of Harvard College Cortistatin analogues and syntheses therof
JP2012524778A (ja) * 2009-04-22 2012-10-18 プレジデント アンド フェロウズ オブ ハーバード カレッジ 血管新生阻害剤
US9388210B2 (en) 2011-02-25 2016-07-12 Washington University Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
EP4717314A2 (en) 2011-10-14 2026-04-01 Sage Therapeutics, LLC 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
DK2935307T3 (en) 2012-12-18 2018-07-30 Univ Washington NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS USED IN METHODS OF TREATMENT
US9512170B2 (en) 2013-03-01 2016-12-06 Washington University Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors
US9365502B2 (en) 2013-03-11 2016-06-14 Washington University Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors
US9562026B2 (en) 2013-03-14 2017-02-07 Washington University Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
SMT202100509T1 (it) 2013-04-17 2021-11-12 Sage Therapeutics Inc Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia
CA2918735C (en) 2013-07-19 2023-08-01 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
CN105579043B (zh) 2013-08-23 2021-09-14 萨奇治疗股份有限公司 神经活性类固醇、组合物和其用途
SG11201605178WA (en) 2013-12-24 2016-07-28 Harvard College Cortistatin analogues and syntheses and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MY190408A (en) 2014-10-16 2022-04-21 Sage Therapeutics Inc Compositions and methods for treating cns disorders
US20170233433A1 (en) 2014-10-16 2017-08-17 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2016082789A1 (en) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
LT3250210T (lt) 2015-01-26 2021-04-12 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti gydyti cns sutrikimus
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
WO2016182932A1 (en) 2015-05-08 2016-11-17 President And Fellows Of Harvard College Cortistatin analogues, syntheses, and uses thereof
EP3316889A4 (en) 2015-07-01 2018-11-14 President and Fellows of Harvard College Cortistatin analogues and syntheses and uses thereof
AU2017283878A1 (en) * 2016-06-15 2019-01-03 Sony Corporation Information processing device, observation system, observation method, and program
CA3030420C (en) 2016-07-11 2025-11-18 Sage Therapeutics, Inc. C7, C12 AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND ASSOCIATED METHODS OF USE
WO2018013613A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C17, c20, and c21 substituted neuroactive steroids and their methods of use
JP7670626B2 (ja) 2019-05-31 2025-04-30 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド及びその組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
GB2331987B (en) * 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
US6046186A (en) * 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
JP2002517449A (ja) * 1998-06-10 2002-06-18 ステリックス リミテッド エストロンスルファターゼの阻害のための腫瘍壊死因子aおよび2−メトキシエストロン−3−o−スルファメートを有する薬学的組成物
JP5042411B2 (ja) * 1999-04-30 2012-10-03 ステリックス リミテッド 抗腫瘍剤としてのエストロン誘導体の使用
JPWO2001081364A1 (ja) * 2000-04-24 2004-01-08 協和醗酵工業株式会社 エストラ−1,3,5(10)−トリエン誘導体
CA2408751A1 (en) * 2000-05-11 2001-11-15 Robert Henry Hesse 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
CA2418479C (en) * 2000-08-18 2007-12-18 The Board Of Trustees Of The University Of Illinois Prodrugs of betulinic acid derivatives for the treatment of cancer
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
WO2002062347A1 (en) 2001-02-05 2002-08-15 Oncology Sciences Corporation Method and composition of novel compounds for the therapy and targeting of the primary modalities of cancer cell proliferation and homeostasis
GB0421106D0 (en) * 2004-09-22 2004-10-27 Sterix Ltd Compound

Similar Documents

Publication Publication Date Title
CA2520142A1 (en) Oestrogen derivatives as inhibitors of steroid sulphatase
CN1091601C (zh) 用苯酚取代的二磷酸酯作抗肿瘤剂
CN102596946B (zh) 抗病毒化合物及其制备和使用方法
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
CN113784970A (zh) Erk抑制剂及其应用
JP2009536191A5 (cg-RX-API-DMAC10.html)
JP7205830B2 (ja) 新規アントラニル酸系化合物、並びにそれを用いたPin1阻害剤、炎症性疾患の治療剤及び癌の治療剤
WO2007139150A1 (ja) TNFα阻害物質を含有してなる抗インフルエンザウイルス剤
JP7302025B2 (ja) 結腸・直腸がんを治療するための薬物の製造におけるfgf21の使用
JP2004531478A5 (cg-RX-API-DMAC10.html)
CA2434028A1 (en) Amino ceramide-like compounds and therapeutic methods of use
JP2002517449A5 (cg-RX-API-DMAC10.html)
JP7229482B2 (ja) 新規アミド系化合物、並びにそれを用いたPin1阻害剤、炎症性疾患の治療剤及び癌の治療剤
ES2945062T3 (es) Derivados de ácido barbitúrico novedosos, su preparación y uso de los mismos como inhibidores de la transmigración de leucocitos y para el tratamiento de enfermedades inflamatorias, enfermedades autoinmunitarias y cáncer
JPH06192201A (ja) 置換フェノール、それらの製造方法および細胞増殖に起因する疾患の治療のためのそれらの使用
WO2019031471A1 (ja) 脂肪性肝疾患の治療剤及び肥満症の治療剤
RU2008138165A (ru) Стероидные соединения в качестве ингибиторов стероидсульфатазы
CN115487177B (zh) 一种黄酮类化合物用于治疗溃疡性结肠炎的新用途
CN104262289B (zh) 一种苯并噻唑衍生物及其抗肿瘤用途
CN106619628B (zh) 苦参碱衍生物在制备预防或治疗绝经后骨质疏松症药物中的应用
WO2017034242A2 (ko) 신규한 카테콜 유도체 및 이를 포함하는 약학적 조성물
WO2001032658A1 (en) Polyazanaphthalene compound and medicinal use thereof
KR101039750B1 (ko) 신규 쿠마린계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 다약제내성 억제용 약학적 조성물
CN101200465B (zh) 一种十氢化萘类化合物及其医药用途
US9796671B2 (en) Aurora kinase inhibitors